Limited Rollout Of New Technology In Japan Is Part Of G-8 Discussions

The Japanese government initially should limit the introduction of breakthrough medical technology to centers of excellence around the country as a first step in generating reimbursement levels, the U.S. Department of Commerce will propose.

More from Archive

More from Medtech Insight